Narendra Kumar

Academic clinical board certified Cardiologist, with nearly 100 publications. doctorate thesis in cardiology on Atrial fibrillation ablation from Maastricht University Medical Centre, Netherlands(ranked among the top 50 clinical universities worldwide). He is also a program chair for an International cardiology program and a visiting professor of cardiology for EDU( Germany, Malta). His primary interests are atrial fibrillation, arrhythmia management, Heart failure, and cardiovascular economics. He has extensive experience with ablation procedures and complex device implantation with >70 publications (and >600 citations) in reputed journals, including JACC and Heart Rhythm Journal. He has more than a decade of experience in Cardiology. Awards -- Erasmus Scholarship 2015 -- NRI of the Year award" 2018 for academics by Times group. -- American Heart Rhythm Society scholarship 2018 for advanced heart arrhythmia training at St Luke's Medical Center, USA. -- American College of Cardiology 2019 travel award. -- EHRA 2021 - Educational Grant -- • India UK Achievers Honours 2023 at UK parliament for contribution to Science, Education, and Innovation He was trained earlier at some of the best hospitals across the USA, UK, Germany, and the Netherlands. He is a fellow of 1] Royal College of Physicians, Edinburg UK (FRCP) 2] European Society of Cardiology (FESC) 3] American College of Cardiology (FACC) 4) Indian College of Cardiodiabetology and Metabolic Disease (FICCMD) His two papers, including the "ATSCA study," have been referenced in the 2017 expert consensus on atrial fibrillation ablation guidelines. He has also worked as a reviewer for journals such as The Lancet and a global consultant for various studies such as Discovery, Painfree-sst, and ImproveSCA. He graduated from the London School of Economics in Health economics and cardiovascular management. He is also responsible for approving the “World’s first catheter for epicardial ventricular tachycardia ablation” from TGA for Abbott(USA).